ConductScience.org, home

Paper5776003

Bacteriologic studies of rifampin, a new semisynthetic antibiotic.

Kunin CM and 2 others. J Infect Dis, 1969. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. Papers, record 5776003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5776003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bacteriologic studies of rifampin, a new semisynthetic antibiotic.
PubMed
Journal
J Infect Dis
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
81
iCite
Revised in PubMed
2019-05-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kunin CMC M
2Brandt DD
3Wood HH

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Adult
Chemical Phenomena
Chemistry
Drug Resistance, Microbial
Enterobacteriaceae
Humans
Male
Staphylococcus
Streptococcus

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
41545350Enzymes-enhanced antibiotic therapy reduces biofilms to undetectable levels in an implant-associated infection model.NPJ Biofilms Microbiomes2026https://conductscience.org/library/papers/41545350PubMed
20065324Rifampin combination therapy for nonmycobacterial infections.Clin Microbiol Rev2010https://conductscience.org/library/papers/20065324PubMed
16495239In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16495239PubMed
7325636Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325636PubMed
7113198Staphylococcal pericarditis-successful nonsurgical treatment with indwelling catheter and antibiotic drugs.West J Med1982https://conductscience.org/library/papers/7113198PubMed
6980623Emergence of rifampin-resistant Haemophilus influenzae.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6980623PubMed
6910479Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.J Clin Pathol1981https://conductscience.org/library/papers/6910479PubMed
6901593Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6901593PubMed
6859835In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6859835PubMed
6732212Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6732212PubMed
5001420Actions of the rifamycins.Bacteriol Rev1971https://conductscience.org/library/papers/5001420PubMed
4999067Clinical uses and control of rifampicin and clindamycin.J Clin Pathol1971https://conductscience.org/library/papers/4999067PubMed
4949280Rifampicin: a review.Drugs1971https://conductscience.org/library/papers/4949280PubMed
4943582Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria.Appl Microbiol1971https://conductscience.org/library/papers/4943582PubMed
4790559Treatment of experimental staphylococcal infection with rifampin.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4790559PubMed
1137380Effect of rifampin on nasal carriage of Staphylococcus aureus.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137380PubMed
1041216BL-P1654: a bacteriostatic penicillin?Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1041216PubMed
666300In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/666300PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5776003

GET https://conductscience.org/api/papers/v1/5776003/authors